National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 2987-2988 [2012-1090]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 13 / Friday, January 20, 2012 / Notices
Place: Renaissance Washington DC
Downtown, 999 Ninth Street NW.,
Washington, DC 20001.
Contact Person: Zhuqing Li, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, (301) 402–
9523, zhuqing.li@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 13, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–1097 Filed 1–19–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review of R34 Clinical Trial
Planning Grants.
Date: February 21, 2012.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Jonathan Horsford, Ph.D.,
Scientific Review Officer, Natl Inst of Dental
and Craniofacial Research, National Institutes
of Health, 6701 Democracy Blvd., Room 664,
Bethesda, MD 20892, (301) 594–4859,
horsforj@mail.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review of R34 Clinical Trial
Planning Grant Applications.
Date: February 28, 2012.
Time: 1 p.m. to 2:30 p.m.
VerDate Mar<15>2010
14:12 Jan 19, 2012
Jkt 226001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Jonathan Horsford, Ph.D.,
Scientific Review Officer, Natl Inst of Dental
and Craniofacial Research, National Institutes
of Health, 6701 Democracy Blvd., Room 664,
Bethesda, MD 20892, (301) 594–4859,
horsforj@mail.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review LRP Applications.
Date: March 28, 2012.
Time: 10 p.m. to 11 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Raj K. Krishnaraju, Ph.D.,
MS, Scientific Review Officer, Scientific
Review Branch, National Inst of Dental &
Craniofacial Research, National Institutes of
Health, 45 Center Dr., Rm. 4AN 32J,
Bethesda, MD 20892, (301) 594–4864,
kkrishna@nidcr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 13, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
2987
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, 242, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, (301) 451–3397,
sukharem@mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, NIBIB BTRC Review
(2012/05).
Date: March 12–14, 2012.
Time: 6 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel—Piscataway/
Somerset, 121 Centennial Avenue,
Piscataway, NJ 08854.
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, (301) 451–3397,
sukharem@mail.nih.gov.
Dated: January 13, 2012.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–1091 Filed 1–19–12; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2012–1096 Filed 1–19–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
Date: February 23, 2012.
Time: 12 p.m. to 6 p.m.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; The NIDDK–KUH
Fellowship Review Committee.
Date: February 17, 2012.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\20JAN1.SGM
20JAN1
wreier-aviles on DSK5TPTVN1PROD with NOTICES
2988
Federal Register / Vol. 77, No. 13 / Friday, January 20, 2012 / Notices
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; R13 Conference
Applications.
Date: February 24, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: D.G. Patel, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 756, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Informed Consent
Ancillary Study.
Date: February 27, 2012.
Time: 3 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Elena Sanovich, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8886,
sanoviche@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Metabolomic
Predicators of Diabetes.
Date: February 29, 2012.
Time: 2 p.m. to 4:40 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: D.G. Patel, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 756, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
VerDate Mar<15>2010
14:12 Jan 19, 2012
Jkt 226001
Dated: January 13, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–1090 Filed 1–19–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2011–0619]
Extension of Public Comment Period;
Mechanisms of Compliance With
United States Citizenship
Requirements for the Ownership of
Vessels Eligible To Engage in
Restricted Trades by Publicly Traded
Companies
Coast Guard, DHS.
ACTION: Notice of extension of public
comment period.
AGENCY:
On November 3, 2011, the
Coast Guard published a Notice and
Request for Comments regarding the
mechanisms of compliance with United
States citizenship requirements for the
ownership of vessels eligible to engage
in restricted trades by publicly traded
companies. In that notice, the public
comment period was set to expire on
February 1, 2012. In today’s action, the
Coast Guard is providing notice that the
public comment period is extended
until April 2, 2012. This extension will
provide the public with additional time
and opportunity to provide the Coast
Guard with information regarding the
relevant compliance mechanisms
employed by companies with a wide
variety of complex organizational
structures and trading practices.
DATES: Comments and related material
must either be submitted to our online
docket via https://www.regulations.gov
on or before April 2, 2012, or reach the
Docket Management Facility by that
date.
SUMMARY:
You may submit comments
identified by docket number USCG–
2011–0619 using any one of the
following methods:
(1) Federal eRulemaking Portal:
https://www.regulations.gov.
(2) Fax: (202) 493–2251.
(3) Mail: Docket Management Facility
(M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001.
(4) Hand delivery: Same as mail
address above, between 9 a.m. and 5
p.m., Monday through Friday, except
ADDRESSES:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Federal holidays. The telephone number
is (202) 366–9329. To avoid duplication,
please use only one of these four
methods. See the ‘‘Public Participation
and Request for Comments’’ portion of
the SUPPLEMENTARY INFORMATION section
below for instructions on submitting
comments.
If
you have questions on this notice, call
or email Mr. Douglas Cameron, United
States Coast Guard, National Vessel
Documentation Center; telephone (304)
271–2506; e-mail
Douglas.G.Cameron@uscg.mil. If you
have questions on viewing or submitting
material to the docket, call Ms. Renee V.
Wright, Program Manager, Docket
Operations, telephone (202) 366–9826.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Public Participation and Request for
Comments
We encourage your participation by
submitting comments and related
materials. All comments received will
be posted, without change, to https://
www.regulations.gov and will include
any personal information you have
provided.
Submitting comments: If you submit
comments, please include the docket
number for the notice (USCG–2011–
0619), indicate the specific section of
the document to which each comment
applies, and provide a reason for each
suggestion or recommendation. You
may submit your comments and
material online, or by fax, mail or hand
delivery, but please use only one of
these means. We recommend that you
include your name and a mailing
address, an email address, or a
telephone number in the body of your
document so that we can contact you if
we have questions regarding your
submission.
To submit your comment online, go to
https://www.regulations.gov, click on the
‘‘Submit a Comment’’ box, which will
then become highlighted in blue. In the
‘‘Document Type’’ drop down menu
select ‘‘Notices’’ and insert ‘‘USCG–
2011–0619’’ in the ‘‘Keyword’’ box.
Click ‘‘Search,’’ and then click on the
balloon shape in the ‘‘Actions’’ column.
If you submit your comments by mail or
hand delivery, submit them in an
unbound format, no larger than 8c by 11
inches, suitable for copying and
electronic filing. If you submit
comments by mail and would like to
know that they reached the Facility,
please enclose a stamped, self-addressed
postcard or envelope. We will consider
all comments and material received
during the comment period.
E:\FR\FM\20JAN1.SGM
20JAN1
]]>Agencies
[Federal Register Volume 77, Number 13 (Friday, January 20, 2012)]
[Notices]
[Pages 2987-2988]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1090]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; The NIDDK-KUH Fellowship
Review Committee.
Date: February 17, 2012.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
[[Page 2988]]
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; R13 Conference
Applications.
Date: February 24, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: D.G. Patel, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 756,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7682,
pateldg@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Informed Consent
Ancillary Study.
Date: February 27, 2012.
Time: 3 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Elena Sanovich, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301)
594-8886, sanoviche@mail.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Metabolomic Predicators
of Diabetes.
Date: February 29, 2012.
Time: 2 p.m. to 4:40 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: D.G. Patel, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 756,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: January 13, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-1090 Filed 1-19-12; 8:45 am]
BILLING CODE 4140-01-P
